Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 5, 1997, Pages 679-686

  Knudsen, Jenny Dahl ^a   Fuursted, Kurt ^a   Frimodt Møller, Niels ^a   Espersen, Frank ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PLASMA PROTEIN BINDING; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0030844078     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.5.679     Document Type: Article

References (22)

1. Appelbaum P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
2. Klugman, K. P. (1990). Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, 171-96.
3. Lonks, J. R. & Medeiros, A. A. (1995). The growing threat of antibiotic-resistant Streptococcus pneumoniae. Medical Clinics of North America 79, 523-35.
4. Hakenbeck, R., Ellerbrok, H., Briese, T., Handwerger, S. & Tomasz, A. (1986). Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the β-lactam binding site. Antimicrobial Agents and Chemotherapy 30, 553-8.
5. Schutze, G. E., Kaplan, S. L. & Jacobs, R. F. (1994). Resistant pneumococcus: a wordwide problem. Infection 22, 233-7.
6. Knudsen, J. D., Frimodt-Møller, N. & Espersen, F. (1995). Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 39, 1253-8.
7. Frimodt-Møller, N., Bentzon, M. W. & Thomsen, V. F. (1986). Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. Journal of Infectious Diseases 154, 511-7.
8. Frimodt-Møller, N., Bentzon, M. W. & Thomsen, V. F. (1987). Experimental pneumococcal infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone. Acta Pathologica Microbiologica et Immunologica Scandinavica 95, 261-7.
9. Poulsen, R. L., Knudsen, J. D., Petersen, M. B., Fuursted, K., Espersen, F. & Frimodt-Møller, N. (1996). In vitro activities of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. Acta Pathologica Microbiologica et Immunologica Scandinavica 104, 227-33.
10. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard M7-A3. NCCLS, Villanova, PA.
11. Chapin-Robertson, K. & Edberg, S. C. (1991). Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), pp. 295-366. Williams and Wilkins, Baltimore, MD.
12. Reed, I. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27, 493-7.
13. Moine, P., Valleé, É., Azoulay-Dupuis, E., Bourget, P., Bédos, J.-P., Bauchet, J. et al. (1994). In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrobial Agents and Chemotherapy 38, 1953-8.
14. Sauve, C., Azoulay-Dupuis, E., Moine, P., Darras-Joly, C., Rieux, V., Carbon, C. et al. (1996). Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2829-34.
15. Kessler, R. E., Bies, M., Buck, R. E., Chisholm, D. R., Pursiano, T. A., Tsai, Y. H. et al. (1985). Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy 27, 207-16.
16. Kim, K. S. & Bayer, A. S. (1985). Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci. Antimicrobial Agents and Chemotherapy 28, 51-4.
17. Tsai, Y. H., Bies, M., Leitner, F. & Kessler, R. E. (1990). Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats. Antimicrobial Agents and Chemotherapy 34, 733-8.
18. Lamb, L. M., Hibbard, J. R., Desiderio, J. V. & Tsai, Y. H. (1993). Efficacy of cefepime in a Staphylococcus aureus endocarditis rat model. Journal of Antimicrobial Chemotherapy 32, Suppl. B, 95-101.
19. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrobial Agents and Chemotherapy 38, 898-900.
20. Hanberger, H. (1992). Pharmacodynamic effect of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time. Scandinavian Journal of Infectious Diseases 81, Suppl., 1-52.
21. Wise, R. (1996). Tissue penetration of the fourth generation parenteral cephalosporins. Journal of Chemotherapy 8, Suppl. 2, 63-70.
22. Amsterdam, D. (1996). Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 52-111. Williams and Wilkins. Baltimore, MD.